A retrospective analysis of 3954 patients in phase 2/3 trials of bortezomib for the treatment of multiple myeloma: towards providing a benchmark for the cardiac safety profile of proteasome inhibition in multiple myeloma.
| Image |  |
|---|---|
| Description | scientific article published on 3 May 2017 |
| Author/s |
author: Huaibao Feng Liviu Niculescu Avinash Desai Hongliang Shi Jacob P Laubach Philippe Moreau Laura Rosiñol Jennifer Elliott María Victoria Mateos Pieter Sonneveld Sagar Lonial Helgi van de Velde Paul G. Richardson Kenneth C. Anderson Robert Z Orlowski Dixie-Lee Esseltine Jesús San Miguel |
| Publication date | May 3, 2017 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |